Show simple item record

FieldValueLanguage
dc.contributor.authorEmerson, E.en
dc.contributor.authorTotsika, V.en
dc.contributor.authorAitken, Z.en
dc.contributor.authorKing, T.en
dc.contributor.authorHastings, R.P.en
dc.contributor.authorHatton, C.en
dc.contributor.authorStancliffe, R.J.en
dc.contributor.authorLlewellyn, G.en
dc.contributor.authorKavanagh, A.en
dc.date.accessioned2021-11-26T05:04:58Z
dc.date.available2021-11-26T05:04:58Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/2123/26986
dc.description.abstractOBJECTIVES: To estimate levels of COVID-19 vaccine hesitancy among working-age adults with disabilities in the United Kingdom. STUDY DESIGN: Cross-sectional survey. METHODS: Secondary analysis of data collected on a nationally representative sample of 10,114 respondents aged 16-64 years. RESULTS: The adjusted relative risk for hesitancy among respondents with a disability was 0.92 (95% CI 0.67-1.27). There were stronger associations between gender and hesitancy and ethnic status and hesitancy among participants with a disability. The most common reasons cited by people with disabilities who were hesitant were: concern about the future effects of the vaccine, not trusting vaccines and concern about the side effects of vaccination. CONCLUSIONS: The higher rates of vaccine hesitancy among women with disabilities and among people from minority ethnic groups with disabilities are concerning.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleVaccine hesitancy among working-age adults with/without disability in the UKen
dc.typeArticleen
dc.identifier.doi10.1016/j.puhe.2021.09.019
dc.relation.otherNational Health and Medical Research Councilen
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.